Advances in Nano‐Immunomodulatory Systems for the Treatment of Acute Kidney Injury
Open Access
- 27 March 2025
- journal article
- review article
- Published by Wiley in Advanced Science
- Vol. 12 (17) , e2409190
Abstract
Acute kidney injury (AKI) occurs when there is an imbalance in the immune microenvironment, leading to ongoing and excessive inflammation. Numerous immunomodulatory therapies have been suggested for the treatment of AKI, the current immunomodulatory treatment delivery systems are suboptimal and lack efficiency. Given the lack of effective treatment, AKI can result in multi‐organ dysfunction and even death, imposing a significant healthcare burden on both the family and society. This underscores the necessity for innovative treatment delivery systems, such as nanomaterials, to better control pathological inflammation, and ultimately enhance AKI treatment outcomes. Despite the modification of numerous immunomodulatory nanomaterials to target the AKI immune microenvironment with promising therapeutic results, the literature concerning their intersection is scarce. In this article, the pathophysiological processes of AKI are outlined, focusing on the immune microenvironment, discuss significant advances in the comprehension of AKI recovery, and describe the multifunctionality and suitability of nanomaterial‐based immunomodulatory treatments in managing AKI. The main obstacles and potential opportunities in the swiftly advancing research field are also clarified.Keywords
Funding Information
- National Natural Science Foundation of China (81873604)
- Youth Science Fund Project (82222039)
This publication has 175 references indexed in Scilit:
- Ultrasmall Nanoparticles Regulate Immune Microenvironment by Activating IL‐33/ST2 to Alleviate Renal Ischemia‐Reperfusion InjuryAdvanced Healthcare Materials, 2024
- Roles of SIRT6 in kidney disease: a novel therapeutic targetCellular and Molecular Life Sciences, 2021
- Association of Oliguria With Acute Kidney Injury Diagnosis, Severity Assessment, and Mortality Among Patients With Critical IllnessJAMA Network Open, 2021
- Redox‐Mediated Artificial Non‐Enzymatic Antioxidant MXene Nanoplatforms for Acute Kidney Injury AlleviationAdvanced Science, 2021
- Sirt6 attenuates hypoxia‐induced tubular epithelial cell injury via targeting G2/M phase arrestJournal of Cellular Physiology, 2019
- Exosomes from human‐bone‐marrow‐derived mesenchymal stem cells protect against renal ischemia/reperfusion injury via transferring miR‐199a‐3pJournal of Cellular Physiology, 2019
- Microbial killing by NK cellsJournal of Leukocyte Biology, 2019
- Formulation and Stability of Cytokine TherapeuticsJournal of Pharmaceutical Sciences, 2015
- Macrophage-mediated injury and repair after ischemic kidney injuryPediatric Nephrology, 2014
- Pathophysiology of Acute Kidney Injury2012